Literature DB >> 8157761

p53 expression in three separate tumours from a patient with Li-Fraumeni's syndrome.

P King1, A W Craft, A J Malcolm.   

Abstract

The Li-Fraumeni cancer syndrome is a rare autosomal dominant syndrome, characterised by the occurrence of diverse mesenchymal and epithelial neoplasms at multiple sites. It has recently been shown that some of these individuals have a germ line mutation of the p53 tumour suppressor gene. The case of one member of such a family who has now developed three separate primary malignant tumours is reported. All three tumours expressed mutant p53 protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8157761      PMCID: PMC501403          DOI: 10.1136/jcp.46.7.676

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  6 in total

1.  Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

Authors:  F P Li; J F Fraumeni
Journal:  Ann Intern Med       Date:  1969-10       Impact factor: 25.391

2.  p53 germline mutations in Li-Fraumeni syndrome.

Authors:  M F Santibáñez-Koref; J M Birch; A L Hartley; P H Jones; A W Craft; T Eden; D Crowther; A M Kelsey; M Harris
Journal:  Lancet       Date:  1991-12-14       Impact factor: 79.321

3.  Two families with the Li-Fraumeni cancer family syndrome.

Authors:  A D Pearson; A W Craft; J M Ratcliffe; J M Birch; P Morris-Jones; D F Roberts
Journal:  J Med Genet       Date:  1982-10       Impact factor: 6.318

4.  Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome.

Authors:  S Srivastava; Z Q Zou; K Pirollo; W Blattner; E H Chang
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

5.  Detection of both mutant and wild-type p53 protein in normal skin fibroblasts and demonstration of a shared 'second hit' on p53 in diverse tumors from a cancer-prone family with Li-Fraumeni syndrome.

Authors:  S Srivastava; Y A Tong; K Devadas; Z Q Zou; V W Sykes; Y Chen; W A Blattner; K Pirollo; E H Chang
Journal:  Oncogene       Date:  1992-05       Impact factor: 9.867

6.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

Authors:  D Malkin; F P Li; L C Strong; J F Fraumeni; C E Nelson; D H Kim; J Kassel; M A Gryka; F Z Bischoff; M A Tainsky
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

  6 in total
  2 in total

1.  Surgery for Li Fraumeni syndrome: pushing the limits of surgical oncology.

Authors:  Russell C Langan; Kiran H Lagisetty; Scott Atay; Prakash Pandalai; Alexander Stojadinovic; Udo Rudloff; Itzhak Avital
Journal:  Am J Clin Oncol       Date:  2015-02       Impact factor: 2.339

2.  Prognostic markers in chondrosarcoma: evaluation of cell proliferation and of regulators of the cell cycle.

Authors:  S P Scully; L J Layfield; J M Harrelson
Journal:  Sarcoma       Date:  1997
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.